These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33913701)

  • 1. Genomic-Led Discovery of a Novel Glycopeptide Antibiotic by
    Yushchuk O; Vior NM; Andreo-Vidal A; Berini F; Rückert C; Busche T; Binda E; Kalinowski J; Truman AW; Marinelli F
    ACS Chem Biol; 2021 May; 16(5):915-928. PubMed ID: 33913701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Master Switch Regulators Trigger A40926 Biosynthesis in Nonomuraea sp. Strain ATCC 39727.
    Lo Grasso L; Maffioli S; Sosio M; Bibb M; Puglia AM; Alduina R
    J Bacteriol; 2015 Aug; 197(15):2536-44. PubMed ID: 25986904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mechanism of glycopeptide resistance in the A40926 producer Nonomuraea sp. ATCC 39727.
    Marcone GL; Beltrametti F; Binda E; Carrano L; Foulston L; Hesketh A; Bibb M; Marinelli F
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2465-72. PubMed ID: 20308385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Molecular Tools for Regulation and Improvement of A40926 Glycopeptide Antibiotic Production in
    Yushchuk O; Andreo-Vidal A; Marcone GL; Bibb M; Marinelli F; Binda E
    Front Microbiol; 2020; 11():8. PubMed ID: 32038594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Two-Component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance.
    Alduina R; Tocchetti A; Costa S; Ferraro C; Cancemi P; Sosio M; Donadio S
    Sci Rep; 2020 Apr; 10(1):6200. PubMed ID: 32277112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926.
    Alduina R; Lo Piccolo L; D'Alia D; Ferraro C; Gunnarsson N; Donadio S; Puglia AM
    J Bacteriol; 2007 Nov; 189(22):8120-9. PubMed ID: 17873036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between glycopeptide production and resistance in the actinomycete Nonomuraea sp. ATCC 39727.
    Marcone GL; Binda E; Carrano L; Bibb M; Marinelli F
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5191-201. PubMed ID: 24957828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Single-Peak Dalbavancin Analogs through Biology and Chemistry.
    Alt S; Bernasconi A; Sosio M; Brunati C; Donadio S; Maffioli SI
    ACS Chem Biol; 2019 Mar; 14(3):356-360. PubMed ID: 30830742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Talking of Pathway-Specific Regulators in Glycopeptide Antibiotics (Teicoplanin and A40926) Production.
    Andreo-Vidal A; Yushchuk O; Marinelli F; Binda E
    Antibiotics (Basel); 2023 Mar; 12(4):. PubMed ID: 37107003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex Regulatory Networks Governing Production of the Glycopeptide A40926.
    Alduina R; Sosio M; Donadio S
    Antibiotics (Basel); 2018 Apr; 7(2):. PubMed ID: 29621136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by nonomuraea species.
    Sosio M; Stinchi S; Beltrametti F; Lazzarini A; Donadio S
    Chem Biol; 2003 Jun; 10(6):541-9. PubMed ID: 12837387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production enhancement of the glycopeptide antibiotic A40926 by an engineered Nonomuraea gerenzanensis strain.
    Yan B; Gao W; Tian L; Wang S; Dong H
    Biotechnol Lett; 2022 Feb; 44(2):259-269. PubMed ID: 34826003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and manipulating glycopeptide pathways: the example of the dalbavancin precursor A40926.
    Sosio M; Donadio S
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):569-76. PubMed ID: 16761167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved A40926 production from Nonomuraea gerenzanensis using the promoter engineering and the co-expression of crucial genes.
    Dong H; Yue X; Yan B; Gao W; Wang S; Li Y
    J Biotechnol; 2020 Dec; 324():28-33. PubMed ID: 32971181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved production of A40926 by Nonomuraea sp. through deletion of a pathway-specific acetyltransferase.
    Sosio M; Canavesi A; Stinchi S; Donadio S
    Appl Microbiol Biotechnol; 2010 Aug; 87(5):1633-8. PubMed ID: 20414653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycopeptide antibiotics: from conventional molecules to new derivatives.
    Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
    Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptomyces spp. as efficient expression system for a D,D-peptidase/D,D-carboxypeptidase involved in glycopeptide antibiotic resistance.
    Binda E; Marcone GL; Berini F; Pollegioni L; Marinelli F
    BMC Biotechnol; 2013 Mar; 13():24. PubMed ID: 23497129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteria.
    Hansen MH; Stegmann E; Cryle MJ
    Curr Opin Biotechnol; 2022 Oct; 77():102767. PubMed ID: 35933924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous Expression Reveals Ancient Properties of Tei3—A VanS Ortholog from the Teicoplanin Producer Actinoplanes teichomyceticus.
    Yushchuk O; Zhukrovska K; Ostash B; Fedorenko V; Marinelli F
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPAHex-A synthetic biology platform for Type IV-V glycopeptide antibiotic production and discovery.
    Xu M; Wang W; Waglechner N; Culp EJ; Guitor AK; Wright GD
    Nat Commun; 2020 Oct; 11(1):5232. PubMed ID: 33067466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.